U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904728) titled 'Treating Contact Lens Discomfort With Cyclosporine 0.1% Ophthalmic Solution' on Oct. 23.

Brief Summary: Of the 140 million contact lens (CL) wearers worldwide, most wear soft contact lenses. Despite major improvements in contact lens care, nearly 20% of wearers stop using lenses, with contact lens discomfort (CLD) being the main reason. This study aims to determine whether VEVYE, a water-free 0.1% cyclosporine ophthalmic solution indicated for the treatment of DED, can improve contact lens comfort in people with dry eye disease.

Study Start Date: Aug. 25

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease (DED) Contact Lens Di...